PET/CT is one of today’s most efficient imaging systems. It is used particularly in the field of oncology, in tumor detection, determining the degree of differentiation of the tumor, radiotherapy planning, assessing response to treatment, and in some cases, determining whether the mass is benign or malignant.
As PET/CT imaging allows simultaneous screening of the whole body, it enables determining whether the disease has spread to other organs or not. PET/CT also provides answers to questions as to whether an active disease is still present after the treatment or not; and how efficient the treatment has been.
PET/CT is also used for identifying epileptogenic focus, in neurologic cases such Alzheimer’s disease, and in detection of viable heart tissue following a heart attack.